Summary of Study ST000502
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000379. The data can be accessed directly via it's Project DOI: 10.21228/M82C8B This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000502 |
Study Title | Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels. |
Study Type | RCT |
Study Summary | RCT of the effect og liraglutide on weight maintenance. 58 individuals wer included and subjected to low calorie intake during 8 weeks. Individuals lost a mean of 12 kg during that period. Individuals were then randomized to receive 1.2 mg liraglutide daily for 1 year or serving as control. Metabolites were measured at inclusion (-8 weeks), randomization (0 weeks) and at 4 and 52 weeks during weight maintenance. |
Institute | NNF Center for Metabolic Research |
Last Name | Engelbrechtsen |
First Name | Line |
Address | Section of Metabolic Genetics, Universitetsparken 1, DIKU building 1st floor, 2100 Copenhagen |
line@sund.ku.dk | |
Phone | +4535333639 |
Submit Date | 2016-11-02 |
Num Groups | 2 |
Total Subjects | 58 |
Analysis Type Detail | NMR |
Release Date | 2016-12-22 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Factors:
Subject type: Humans; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Time(weeks) |
---|---|---|
SA026099 | 4_29 | 4 | Treatment:Control |
SA026100 | 4_28 | 4 | Treatment:Control |
SA026101 | 4_26 | 4 | Treatment:Control |
SA026102 | 4_51 | 4 | Treatment:Control |
SA026103 | 4_24 | 4 | Treatment:Control |
SA026104 | 4_46 | 4 | Treatment:Control |
SA026105 | 4_22 | 4 | Treatment:Control |
SA026106 | 4_40 | 4 | Treatment:Control |
SA026107 | 4_35 | 4 | Treatment:Control |
SA026108 | 4_34 | 4 | Treatment:Control |
SA026109 | 4_49 | 4 | Treatment:Control |
SA026110 | 4_11 | 4 | Treatment:Control |
SA026111 | 4_8 | 4 | Treatment:Control |
SA026112 | 4_21 | 4 | Treatment:Control |
SA026113 | 4_7 | 4 | Treatment:Control |
SA026114 | 4_58 | 4 | Treatment:Control |
SA026115 | 4_1 | 4 | Treatment:Control |
SA026116 | 4_12 | 4 | Treatment:Control |
SA026117 | 4_42 | 4 | Treatment:Control |
SA026118 | 4_54 | 4 | Treatment:Control |
SA026119 | 4_20 | 4 | Treatment:Control |
SA026120 | 4_15 | 4 | Treatment:Control |
SA026121 | 4_44 | 4 | Treatment:GLP-1 analogue |
SA026122 | 4_52 | 4 | Treatment:GLP-1 analogue |
SA026123 | 4_43 | 4 | Treatment:GLP-1 analogue |
SA026124 | 4_45 | 4 | Treatment:GLP-1 analogue |
SA026125 | 4_53 | 4 | Treatment:GLP-1 analogue |
SA026126 | 4_50 | 4 | Treatment:GLP-1 analogue |
SA026127 | 4_48 | 4 | Treatment:GLP-1 analogue |
SA026128 | 4_57 | 4 | Treatment:GLP-1 analogue |
SA026129 | 4_47 | 4 | Treatment:GLP-1 analogue |
SA026130 | 4_17 | 4 | Treatment:GLP-1 analogue |
SA026131 | 4_23 | 4 | Treatment:GLP-1 analogue |
SA026132 | 4_14 | 4 | Treatment:GLP-1 analogue |
SA026133 | 4_5 | 4 | Treatment:GLP-1 analogue |
SA026134 | 4_39 | 4 | Treatment:GLP-1 analogue |
SA026135 | 4_2 | 4 | Treatment:GLP-1 analogue |
SA026136 | 4_25 | 4 | Treatment:GLP-1 analogue |
SA026137 | 4_10 | 4 | Treatment:GLP-1 analogue |
SA026138 | 4_27 | 4 | Treatment:GLP-1 analogue |
SA026139 | 4_38 | 4 | Treatment:GLP-1 analogue |
SA026140 | 4_37 | 4 | Treatment:GLP-1 analogue |
SA026141 | 4_36 | 4 | Treatment:GLP-1 analogue |
SA026142 | 4_30 | 4 | Treatment:GLP-1 analogue |
SA026143 | 4_31 | 4 | Treatment:GLP-1 analogue |
SA026144 | 4_33 | 4 | Treatment:GLP-1 analogue |
SA026145 | 52_29 | 52 | Treatment:Control |
SA026146 | 52_46 | 52 | Treatment:Control |
SA026147 | 52_41 | 52 | Treatment:Control |
SA026148 | 52_15 | 52 | Treatment:Control |
SA026149 | 52_28 | 52 | Treatment:Control |
SA026150 | 52_34 | 52 | Treatment:Control |
SA026151 | 52_42 | 52 | Treatment:Control |
SA026152 | 52_22 | 52 | Treatment:Control |
SA026153 | 52_21 | 52 | Treatment:Control |
SA026154 | 52_20 | 52 | Treatment:Control |
SA026155 | 52_58 | 52 | Treatment:Control |
SA026156 | 52_6 | 52 | Treatment:Control |
SA026157 | 52_26 | 52 | Treatment:Control |
SA026158 | 52_3 | 52 | Treatment:Control |
SA026159 | 52_1 | 52 | Treatment:Control |
SA026160 | 52_7 | 52 | Treatment:Control |
SA026161 | 52_8 | 52 | Treatment:Control |
SA026162 | 52_40 | 52 | Treatment:Control |
SA026163 | 52_12 | 52 | Treatment:Control |
SA026164 | 52_11 | 52 | Treatment:Control |
SA026165 | 52_39 | 52 | Treatment:GLP-1 analogue |
SA026166 | 52_57 | 52 | Treatment:GLP-1 analogue |
SA026167 | 52_52 | 52 | Treatment:GLP-1 analogue |
SA026168 | 52_38 | 52 | Treatment:GLP-1 analogue |
SA026169 | 52_48 | 52 | Treatment:GLP-1 analogue |
SA026170 | 52_47 | 52 | Treatment:GLP-1 analogue |
SA026171 | 52_44 | 52 | Treatment:GLP-1 analogue |
SA026172 | 52_45 | 52 | Treatment:GLP-1 analogue |
SA026173 | 52_43 | 52 | Treatment:GLP-1 analogue |
SA026174 | 52_18 | 52 | Treatment:GLP-1 analogue |
SA026175 | 52_14 | 52 | Treatment:GLP-1 analogue |
SA026176 | 52_16 | 52 | Treatment:GLP-1 analogue |
SA026177 | 52_10 | 52 | Treatment:GLP-1 analogue |
SA026178 | 52_9 | 52 | Treatment:GLP-1 analogue |
SA026179 | 52_2 | 52 | Treatment:GLP-1 analogue |
SA026180 | 52_5 | 52 | Treatment:GLP-1 analogue |
SA026181 | 52_17 | 52 | Treatment:GLP-1 analogue |
SA026182 | 52_19 | 52 | Treatment:GLP-1 analogue |
SA026183 | 52_30 | 52 | Treatment:GLP-1 analogue |
SA026184 | 52_36 | 52 | Treatment:GLP-1 analogue |
SA026185 | 52_27 | 52 | Treatment:GLP-1 analogue |
SA026186 | 52_25 | 52 | Treatment:GLP-1 analogue |
SA026187 | 52_23 | 52 | Treatment:GLP-1 analogue |
SA026188 | 52_37 | 52 | Treatment:GLP-1 analogue |
SA025996 | -8_26 | -8 | Treatment:Control |
SA025997 | -8_49 | -8 | Treatment:Control |
SA025998 | -8_24 | -8 | Treatment:Control |
SA025999 | -8_51 | -8 | Treatment:Control |
SA026000 | -8_22 | -8 | Treatment:Control |
SA026001 | -8_28 | -8 | Treatment:Control |
SA026002 | -8_40 | -8 | Treatment:Control |
SA026003 | -8_29 | -8 | Treatment:Control |
SA026004 | -8_42 | -8 | Treatment:Control |
SA026005 | -8_41 | -8 | Treatment:Control |